Overview

A Trial Comparing Observation With Radiation on Pelvic Lymphocysts After Radical Hysterectomy of Cervical Cancer

Status:
Recruiting
Trial end date:
2025-03-31
Target enrollment:
Participant gender:
Summary
Cervical cancer of early stage is treated mainly by radical resection and (or) radiotherapy. And pelvic lymphocyst is one of the most common adverse events of radical resection. The aim of this study is to compare observation with radiation on pelvic lymphocyst of cervical cancer patients after radical resection, for incidence of adverse events and local recurrence rate.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Treatments:
Cisplatin